Anestol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anestol

Quick Facts

Property Description
Active Ingredient Lidocaine Hydrochloride
Form Topical Ointment (Semi-solid preparation)
Pharmacological Class Local Anesthetic Agent
Common Use Surface Analgesia, Local Pain Relief
Origin Synthetic

What Type of Medicine is Anestol? (Identity and Classification)

Anestol is a synthetic pharmaceutical preparation designated as a Local Anesthetic Agent. The medication is classified as an amide-type local anesthetic, functioning as a monotherapy that contains a single active substance to provide surface analgesia. This classification distinguishes it chemically from other anesthetic types, confirming its targeted and localized mechanism. Lidocaine is categorized as an essential medicine for local anesthesia. This recognition underscores the substance's reliability and crucial role in providing fundamental local pain relief.

Anestol’s Active Ingredient and Form (Composition and Physical Nature)

The key active component in Anestol is the compound Lidocaine, administered specifically as its salt, Lidocaine Hydrochloride. This active substance is formulated into a Topical Ointment, a semi-solid preparation designed exclusively for cutaneous administration. The composition includes Lidocaine Hydrochloride dispersed within an inert ointment base, which contains stabilizing emollients that facilitate sustained contact with the skin surface. This dermatological preparation allows for the targeted delivery of the Lidocaine, which is clinically recognized for its reliable onset of action compared to certain other surface anesthetics, making it suitable for quick symptomatic relief.

How Does Anestol Provide Localized Relief? (High-Level Mechanism and Purpose)

Anestol provides relief by directly stabilizing the neuronal membrane of nerves in the peripheral nervous system, inhibiting the transmission of pain signals. The Lidocaine molecule achieves this by blocking the fast voltage-gated Sodium Channels, which are necessary for the initiation of the electrical impulse. By preventing the flow of ions required for signal propagation, the medication causes a temporary, localized interruption of nerve impulse transmission, resulting in a defined area of numbness. This mechanism confirms its dedicated role as a Local Anesthetic Agent for achieving targeted surface analgesia confined to the skin surface, a feature supported by pharmacological studies demonstrating its high affinity for nerve membranes.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. NIH MedlinePlus

What side effects are possible with Anestol?

Official Adverse Effects and Safety Characteristics

The safety profile of Anestol, which contains Lidocaine Hydrochloride as a topical ointment, is primarily characterized by effects concerning the Skin and Subcutaneous Tissue Disorders. The most frequently documented reactions are common and typically localized to the application site, including manifestations of local irritation such as erythema (redness), pruritus (itching), rash, and minor edema (swelling). Less frequently, contact dermatitis is classified as an uncommon reaction, representing a localized immunological response.

From the perspective of Immune System Disorders, rare instances of severe hypersensitivity reactions have been reported, including anaphylaxis and angioedema. The product is restricted from use in individuals with a known history of allergy to amide-type local anesthetics.

While designed for localized action, the potential for systemic absorption is a critical, though rare, safety consideration. If excessive systemic absorption occurs, signs of Systemic Toxicity affecting the Nervous System Disorders and Cardiac Disorders may manifest. Serious adverse reactions in this context include Central Nervous System (CNS) toxicity (e.g., tremors, seizures) and cardiac effects (e.g., bradycardia, cardiovascular collapse).

Risk of systemic effects is heightened with prolonged or extensive use, application over large surface areas, or use on compromised skin. Safety consideration is specifically required for individuals with severe hepatic impairment, as the liver is the primary site of lidocaine metabolism.

Overdose and Emergency Response

Overdose and Systemic Manifestations

Overdose with Anestol (Lidocaine Topical) results from excessive systemic absorption of the active ingredient, leading to signs of toxicity. Documented initial clinical manifestations involve the Central Nervous System (CNS), presenting as lightheadedness, nervousness, apprehension, confusion, dizziness, tinnitus (ringing in the ears), blurred or double vision, and muscle twitching. These excitatory signs may be followed by CNS depression, drowsiness, and unconsciousness.

Severe Outcomes and Emergency Actions

Severe or life-threatening outcomes documented in regulatory warnings include the risk of convulsions, which may lead to respiratory arrest, subsequent hypoxia, and cardiovascular collapse or cardiac arrest. A serious complication that may occur is methemoglobinemia, typically identifiable by pale, gray, or blue-colored skin, alongside headache and shortness of breath.

When to Seek Help: Regulatory authorities mandate that individuals experiencing severe symptoms, such as convulsions, trouble breathing, inability to awaken, or any signs of methemoglobinemia, must seek immediate medical attention. Management requires immediate attention to maintaining a patent airway and providing assisted ventilation with oxygen. No specific antidote is known for lidocaine toxicity itself; therefore, treatment is symptomatic and supportive. Population-specific considerations note that children are at a greater risk of severe toxicity, including severe brain injury.

Therapeutic Uses of Anestol

What Anestol treats: Main Uses and Benefits

Anestol is commonly used to provide symptomatic support during the acute phase of conditions presenting with systemic or localized discomfort. The medication is applied to help relieve pain and itching caused by conditions such as minor cuts, scrapes, sunburn, minor burns, and insect bites.

This medication is relevant for addressing symptoms related to inflammatory or irritative states, notably heightened burning, stinging, and persistent itching (pruritus). The application provides supportive numbing that contributes to easing the initial sharp discomfort and soreness associated with superficial trauma, and is used for managing symptoms that create noticeable physiological strain in situations where symptoms become more noticeable.

It is also utilized for specific clinical needs, such as providing temporary symptomatic support for soreness associated with anorectal discomfort (e.g., hemorrhoids), and may assist in increasing patient comfort before minor dermal procedures.

Quick Fact: Relief for Localized Surface Pain The benefit of this numbing effect is that it helps patients cope more steadily with temporary functional strain and acute symptom manifestations.

“This topical agent is commonly used to achieve localized anesthesia, which assists with maintaining functional stability during periods of acute surface irritation.”

Regulatory References

  1. NIH MedlinePlus overview on topical lidocaine

Eligibility and Restrictions for Use

Eligibility and Contraindications for Anestol

Official regulatory documents define specific populations who are restricted from using Anestol (Lidocaine Topical Ointment). The use of this medicine is contraindicated in patients with a known history of hypersensitivity to lidocaine or any local anesthetics of the amide-type. Absolute prohibition may also apply to patients with specific severe systemic conditions like certain types of heart block or severe shock.

Age and Health Restrictions

  • Pediatric Use: Use in children must be at reduced doses commensurate with age and physical status. The FDA advises against use for teething pain in infants due to the risk of systemic toxicity.
  • Vulnerable Adults: Elderly and acutely ill patients are also required to receive reduced doses and should be used with caution.
  • Organ Function: Patients with severe hepatic (liver) disease must use the medication with caution due to the risk of toxic accumulation. Caution is also advised in cases of severe renal impairment.
  • Pregnancy and Lactation: Lidocaine is classified as Pregnancy Category B, but there are no adequate studies in pregnant women. Lidocaine is excreted into human milk, requiring caution during breastfeeding.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Anestol (lidocaine topical ointment) identifies several drug and substance categories that may alter the concentration or effects of the active ingredient, particularly if systemic absorption occurs.

Pharmacokinetic (PK) and Exposure Interactions

Classification Interacting Agents (Examples) Regulatory Description
Clearance Reduction Cimetidine, Propranolol (Beta-blockers) Reduce plasma clearance by inhibiting metabolism or decreasing hepatic blood flow, potentially increasing lidocaine concentration.
Metabolic Modulation CYP1A2/CYP3A4 Inhibitors (Fluvoxamine) Decrease lidocaine clearance and may prolong the elimination half-life.
Metabolic Modulation CYP1A2/CYP3A4 Inducers (Phenytoin) Accelerate plasma clearance, potentially decreasing lidocaine levels.

Pharmacodynamic (PD) and Risk Reinforcement

Classification Interacting Agents (Examples) Regulatory Description
Additive Cardiac Effects Class I Antiarrhythmic Agents Simultaneous use should be avoided due to the documented risk of serious additive cardiac effects.
Methemoglobinemia Risk Other Local Anesthetics, Oxidizing Agents (Nitrates) Increases the risk of developing methemoglobinemia when co-administered.

Constraints and Special Considerations

  • Total Exposure: When multiple products containing the active substance are used, the total dose contributed by all formulations must be kept in mind to avoid high systemic levels.
  • Route-Specific Timing: For mucosal or oral lidocaine preparations, a 60-minute separation from food or liquid intake is required due to the risk associated with impaired swallowing.
  • Population Note: Caution is required for patients with impaired hepatic function or those who are elderly or acutely ill, as reduced drug clearance may increase the chance of systemic interaction effects.

Mechanism of Action

Direct Blockade of Peripheral Sodium Channels

Anestol's mechanism of action is defined by the reversible blockade of Voltage-Gated Sodium Channels (NaV channels) on peripheral sensory neurons. This molecular interference prevents the essential transient influx of sodium ions (Na^+) across the nerve membrane, which is required for the nerve cell to generate an electrical impulse, or action potential. The active form of the molecule binds within the channel pore when it is in the activated or inactivated state, stabilizing the nerve cell membrane in a non-excitable state. This physiological step causes a temporary, localized interruption of nerve impulse transmission within the sensory pathway.

The Role of Use-Dependence and Tissue pH

The mechanism exhibits use-dependence, preferentially favoring blockade in highly active nerves. However, the effectiveness of the mechanism is constrained by tissue chemistry; in acidic environments, the active molecule is less able to penetrate the lipophilic neuronal membrane to reach its internal binding site. This constraint results in a reduced intensity and slower development of the channel blockade.

Dosage and Administration Information

General Principles of Use

Anestol, which contains the active ingredient Lidocaine, is officially approved for topical administration as a 5% ointment, meaning it is applied directly to the body surface. This route of use applies to both the skin (cutaneous) and accessible mucous membranes. The ointment is used on an intermittent, symptom-driven basis, with the frequency typically set at three or four times a day for minor skin conditions, always respecting the total daily limits established by regulatory authorities.

Official Administration and Dosing Constraints

The usage of the ointment is strictly governed by quantitative limits to control systemic exposure. For adults, a single application should not exceed 5 grams of the 5% ointment, which is approximately the equivalent of a six-inch length squeezed from the tube. The official maximum quantity of Lidocaine allowed in any 24-hour period must not exceed 1000 mg of the Lidocaine base, which equates to 17 g to 20 g of the ointment.

Procedural Requirements: The medication is generally applied as a thin film. When used on the oral mucosa or other non-skin surfaces, the area should be dried beforehand, and care should be taken to minimize swallowing. When applying the ointment to broken skin, the use of a sterile gauze pad is suggested as an application technique.

Population-Specific Use Rules

Official prescribing information mandates dosage adjustments for certain populations. For children, the dose must be strictly reduced based on age, physical condition, and body weight, and must not exceed 4.5 mg of Lidocaine per kilogram of body weight. Reduced doses are also specified for older or acutely ill patients. When using Anestol alongside any other product containing Lidocaine, the total cumulative dose from all sources must be meticulously calculated to ensure the 1000 mg daily maximum is not breached.

Recent Clinical Evidence

Research evidence / Overview of studies for Anestol (Topical Lidocaine)


Evidence for Temporary Relief of Minor Cuts, Scrapes, and Burns

Research has examined the use of topical Lidocaine formulations for providing short-term symptomatic support from common skin discomforts, such as those that arise from minor cuts, scrapes, sunburn, and minor burns. These investigations mainly involve short-term clinical trials that monitor pain intensity and the severity of itching (pruritus) following application. Studies described patterns related to the duration of the measured analgesic effect immediately after application, reporting measurements related to how symptoms changed in the observed populations.

The evidence quality varies across studies, and there is a documented scarcity of recent, large-scale, independent Randomized Controlled Trials (RCTs) specifically dedicated to this broad group of minor skin issues. This means that while research contributes to understanding symptom patterns, the evidence base for these common uses is based on limited or non-homogenous trials.

Evidence for Temporary Relief of Anorectal Discomfort

Topical Lidocaine was studied for use as a temporary, symptomatic application for conditions associated with acute or disruptive episodes, such as pain, burning, and itching linked to hemorrhoids and other anorectal discomfort. These controlled clinical trials focus on outcomes related to physical discomfort. Findings indicate that the documented outcomes reflect patterns of temporary, localized change in sensation that can be observed during short-term, acute flare-ups.

Follow-up durations were limited across the available studies, as the product is typically applied in studies examining short-term or episodic symptom patterns during acute phases. Therefore, there is limited information for long-term outcomes or the effect of sustained daily use beyond the acute treatment window.

Evidence for Surface Analgesia in Minor Procedures

The use of topical Lidocaine to provide surface analgesia before minor medical events, such as needle insertions, was evaluated in numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. Key outcomes measured include the change in patient-reported pain scores during the procedure itself and the time to a measured change in sensation.

The evidence quality varies across studies based on the specific formulation used. The strongest evidence was associated with high-concentration patches or specialized eutectic mixtures, and it is unclear if the standard ointment can achieve the same measured analgesic patterns in this setting.

Key Studies & References

  1. WHO Model List of Essential Medicines (Relevant section on local anesthetics)
  2. NIH MedlinePlus: Lidocaine Topical

Frequently Asked Questions (FAQ)

Common questions about Anestol (FAQ)

Q: What is the main reason Anestol is prescribed?

Official indications state that the product is intended for providing temporary, localized relief of pain, itching, or burning sensations. This applies to surface discomforts, including those arising from minor cuts, scrapes, minor burns, insect bites, and specific anorectal discomforts.

Q: Can Anestol be used for purposes other than the main approved condition?

Official patient information states that the medicine is indicated only for the specific conditions listed in the approved labeling. Use of the product for any other condition or purpose is not recommended outside of the approved indications and should be discussed with a healthcare professional.

Q: How quickly can one expect to notice effects after using Anestol?

The development of the localized numbing effect is generally rapid. Official pharmacological data for various topical lidocaine formulations often notes that the onset of action occurs within a few minutes following application to the skin surface.

Q: Does Anestol cause drowsiness or affect alertness?

Drowsiness is not an expected side effect when the product is used topically as directed. However, official warnings note that if excessive amounts are absorbed into the bloodstream, drowsiness, dizziness, and confusion are recognized signs of rare systemic toxicity affecting the central nervous system.

Q: Does Anestol have a risk of dependence or addiction?

Based on its pharmacological classification and regulatory information, lidocaine topical ointment is not associated with any known risk of physical dependence or addiction.

Q: What happens if a person misses a planned use of Anestol?

Official patient information states that if an application is missed, it is generally advised to apply it as soon as possible. However, if it is almost time for the next scheduled application, the missed dose is generally skipped to maintain the regular schedule. Regulatory guidance states that extra product must not be applied to compensate for a missed dose.

Q: Is there a maximum period of time Anestol is typically used?

For non-prescription use of topical lidocaine, official labeling typically recommends a maximum period of no more than seven days. If the symptoms or condition persist or worsen after this time, a healthcare professional should be consulted.

Q: Does Anestol interact with common pain relievers or supplements?

Official product information states that for topical use as directed, the risk of systemic interaction with other medicines is low. However, caution is advised with Class I antiarrhythmic agents and certain oxidizing agents due to the potential for additive effects. Specific regulatory data regarding interactions with common non-prescription pain relievers or herbal supplements is often limited.

Q: Is it necessary to avoid certain foods or drinks while using Anestol?

When Anestol is used as a topical ointment on the skin, there are typically no required restrictions on food or drink intake. It is important to know that for oral or mucosal lidocaine preparations, official guidelines recommend avoiding food and drink for at least 60 minutes after use. This separation is necessary to prevent the risk of impaired swallowing due to numbness.

Q: Do any official sources provide information on long-term use of Anestol?

Regulatory guidelines for non-prescription topical lidocaine generally limit use to no more than seven days. This limitation is due to the potential for increased systemic absorption over time, and use beyond this period requires oversight from a healthcare professional.

Q: How long do the effects of Anestol typically last?

The total duration of the local numbing effect is subject to individual variation and the site of application. While the immediate localized effect is temporary, official pharmacological data indicates that once the active substance is absorbed into the bloodstream, the substance's elimination half-life is typically 1.5 to 2 hours in healthy adults.

Q: Does Anestol contain any common allergens like lactose or gluten?

Official product information lists all inactive ingredients used in the ointment base, such as emollients and stabilizers. While these lists do not typically include common food-grade allergens like lactose or gluten, known hypersensitivity to the active ingredient or other amide-type anesthetics remains an absolute contraindication for use.

Q: What is the purpose of the inactive ingredients in Anestol?

The inactive ingredients, which form the ointment base, serve a crucial functional role. Their purpose is to act as a vehicle for the active ingredient, maintain the product's stability, and facilitate sustained contact and effective absorption of the lidocaine into the skin surface.

Q: Are there any long-term known side effects associated with Anestol use?

Official regulatory documents focus predominantly on the safety profile related to acute and short-term use. Because of the limited long-term data available and the potential for cumulative systemic absorption, non-prescription use is typically limited to a short duration, such as seven days, based on safety data.

Q: Is it normal to feel a certain way when starting Anestol?

Initial application may result in common and temporary local skin reactions, such as mild redness, itching, or a transient burning sensation at the site of application. These reactions are typically mild and self-resolving. Any persistent or severe reaction may warrant consultation with a healthcare provider.

Q: What should be done if someone suspects an interaction after using Anestol with another product?

All serious suspected adverse effects or signs of systemic toxicity warrant immediate attention from a healthcare provider. Regulatory guidelines stipulate that discontinuation of the product is necessary, and urgent medical attention should be sought immediately.

Q: Are there any known interactions between Anestol and herbal remedies?

Official patient information acknowledges that there is limited specific data available concerning interactions between lidocaine and various herbal remedies or supplements. This is because these products are generally not tested for their potential effect on the prescription medication.

Q: What warnings exist regarding driving or operating machinery while using Anestol?

When the topical ointment is used exactly as directed, an effect on the ability to drive or operate machinery is not expected. However, because rare systemic side effects like drowsiness or dizziness are possible with over-absorption, these activities are generally advised to be avoided if such symptoms are experienced.

How should Anestol be stored and disposed of?

How to Store and Dispose of Anestol (Lidocaine Topical Ointment)

Official Storage Requirements

Storage Category Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Prohibitions Do not freeze the ointment, and protect it from excessive heat, moisture, and direct light.
Container Rule Keep the product in its original container with the cap tightly closed when not in use.
Child Safety The container must be stored out of the reach of children to prevent accidental ingestion.

Official Disposal Instructions

Expired or unused Anestol should be disposed of in a manner that protects the environment and prevents unauthorized access. The preferred method for disposal is using a medicine take-back program or a DEA-authorized collection site.

If no take-back program is available, the product should not be flushed down a toilet or poured down a drain. Instead, the medication should be mixed with an undesirable substance, placed into a sealed container, and then discarded in the household trash, following the recommendations of regulatory health authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Anestol found in:

A-Z Index: